Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

RADeep Multicenter European Epidemiological Platform for Patients Diagnosed With Rare Anemia Disorders (RADs)

A Retrospective/Prospective, Multicenter European Epidemiological Platform for Patients Diagnosed With Rare Anemia Disorders (RADs) With Clinical Significance.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Rare Anaemia Disorders (RADs) is a group of rare diseases characterized for presenting anaemia as the main clinical manifestation. Different medical entities classified as RADs by ORPHA classification are most of them chronic life threating disorders with many unmet needs for their proper clinical management creating an impact on European health systems. RADs present diagnostic challenges and their appropriate management requires from specialised multidisciplinary teams in Centers of expertise. Although there are some examples of well-established national registries on RADs in EU, the lack of recommendations for Rare disease registries implementation and the lack of standards for interoperability has led to the fragmentation or unavailability of data on prevalence, survival, main clinical manifestations or treatments in most of the European countries.

Who May Be Eligible (Plain English)

Who May Qualify: - Patients must meet all of the following criteria to be included in the RADeep Registry - Age from 0-100, both female and male - Diagnosed as RADs (SCD, THAL, PKD, and other RADs THAL according to ORPHANET classification) - Able and willing to provide written willing to sign a consent form (patient or legal representative for minors) Who Should NOT Join This Trial: - Patient or legal representative for minors unwilling or unable to give consent - Patients diagnosed with SCD or THAL (alpha-thalassaemia and beta-thalassaemia) traits or trait conditions for other recessive RADs Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Patients must meet all of the following criteria to be included in the RADeep Registry * Age from 0-100, both female and male * Diagnosed as RADs (SCD, THAL, PKD, and other RADs THAL according to ORPHANET classification) * Able and willing to provide written informed consent (patient or legal representative for minors) Exclusion Criteria: * Patient or legal representative for minors unwilling or unable to give consent * Patients diagnosed with SCD or THAL (alpha-thalassaemia and beta-thalassaemia) traits or trait conditions for other recessive RADs

Treatments Being Tested

OTHER

Data collection from EHR.

Collection of clinical and laboratory data. Reviwe of the electronic health record

Locations (1)

Vall d'hebron Research Institute - Vall d'Hebron Research Institute - University Hospital Vall d'Hebrón (VHIR/HUVH)
Barcelona, Catalonia, Spain